Skip to content

Clinical trials

Completed Phase 2/3 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2/3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20151
20161
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong2
Bristol-Myers Squibb1
French National Agency for Research on AIDS and Viral Hepatitis1
International Centre for Diarrhoeal Disease Research, Bangladesh1
Jiangsu Province Centers for Disease Control and Prevention1
LG Chem1
National Taiwan University Hospital1
Sheffield Teaching Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B9
Communicable Diseases1
Diphtheria1
HIV Infections1
HIV Seropositivity1
Haemophilus Infections1
Hepatitis B, Chronic1
Inflammatory Bowel Diseases1
Poliomyelitis1
Tetanus1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.